In recent years, Alcor has benefited from cryptocurrency donations. In fact, our largest ever research donation of $5,000,000 from Brad Armstrong was in the form of donated cryptocurrency (Stellar). This immediately led to the creation of the Hal Finney Cryonics Research Fund. Although we don’t have a formal survey, it’s clear that Alcor members are far more likely to own some cryptocurrency as compared to the general public.
With Bitcoin up several hundred percent over the last year – and larger gains for some other currencies such as Ethereum – some of our members may be sitting on heavily appreciated assets that are increasingly coming under scrutiny by the tax authorities.
Are you one such member? If so, consider donating to Alcor. Because you would be giving to a tax-exempt non-profit organization, you would both benefit and strengthen Alcor and reduce your tax liability. This is a relatively painless way to contribute.
A-3024 was a 68-year-old male with inoperable brain cancer who had neuro cryopreservation arrangements. Legal death was declared in Northern California, USA, and the stabilization team arrived seven hours later, four hours after being notified. After stabilization and field neuro cryoprotection, the patient was transported to Alcor for cryogenic cooldown.
A full case report is being prepared.
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2021-05-23 23:42:112021-06-10 23:15:24A-3024 became Alcor’s 182nd patient in April 2021
As a tax-exempt non-profit organization, an important part of Alcor’s mission is to educate the public about cryonics. The final plank of our Mission Statement is: “Awareness and growth of cryonics by educating the public.” We have done that though one-on-one conversations, media interviews for radio, TV, and documentaries, by giving talks at conferences and online events, and by giving tours. We have done very little with podcasts, with one or two recent exceptions – but those came to use rather than us approaching them.
Do you enjoy listening to podcasts? Do you think podcasts could be a productive venue for Alcor to educate a wider audience? And potentially to attract new members? If so, which podcasts do you think would have a good audience for Alcor?
Personally, I much preferring reading to listening, so I don’t pretend to know much about the podcast universe. Even so, to stir your brain up, here are some possibly-promising podcasts that I had either heard of or found with a search:
The Joe Rogan Experience
Stuff You Should Know
The Skeptics’ Guide to the Universe
The Naked Scientists Podcast
The Science Show
Science Friday
StarTalk Radio
Big Picture Science
Flash Forward
Here We Are
Science Talk
Get WIRED
Exponential View with Azeem Azhar
The WIRED UK Podcast
Would you recommend any of these? Or do you have better options? Do you have any connections with the hosts or producers?
As we look ahead to the near future – when we have the conditions in place for faster growth – we want to develop better knowledge of previously unexploited opportunities to have an informative and appealing cryo conversation. We want your input! Email me.
Max More
Ambassador & CEO Emeritus
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2021-04-23 02:56:252021-04-23 02:56:28Tell us your favored podcasts if they might be interested in cryonics
On February 23, Alcor turned 49 years old. If you’re read my recent two-part article in Cryonics on organizational longevity, you’ll know that’s already a relatively impressive run. We will have to keep the organization humming for decades to come but next year’s 50th anniversary offers a good opportunity to celebrate Alcor’s longevity. It might not be too much of a stretch to hope for an Alcor-50 in-person conference in 2022 (perhaps 18 months from now). If that doesn’t work out, we still have the option of an online event. Although not the same as in-person, I’ve attended several excellent online conferences. As people gain more experience, they keep improving.
If you have been flourishing financially, you might think about making a major 50th-year gift for Alcor. The organization can always use new resources to improve our ability to serve, cryopreserve, and care for members and patients. Gifts will be well-used to sustain and build Alcor’s member-focused capabilities.
There are more promising research opportunities than we can fund despite some remarkable contributions to the Research Fund in recent years. (Such as our current RAPID initiative.) The Endowment would benefit from being both replenished and strengthened. I have made modest contributions to both those funds and encourage others to do so. Alcor would also benefit from more resources to build response capabilities and to grow membership to bolster the organization.
–Max More
Alcor Ambassador & CEO Emeritus
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2021-03-12 00:46:012021-03-12 00:46:04Alcor enters its 50th Year
Curious about the number of Alcor members and patients, where they are, and how many are neuro and who many whole body? You can find the numbers for the end of the previous month on the website here:
But that what you find there may not satisfy. Here’s a more complete update, as of January 31, 2021:
Members: 1,338 (“Member” here means a person with full contractual and financial arrangements to be cryopreserved by Alcor.) 641 neuro; 655 WB; 12 N/WB.
There were 96 applicants in the process of becoming members.
How are members distributed internationally? After the US, not surprisingly the country with the largest number of (full) members is our neighbor, Canada. Third place goes to the United Kingdom with 40. Here’s the full list:
Country Members/Associates/Patients
Australia 11 5 3
Austria 1 0 0
Belgium 1 0 0
Brazil 1 0 0
Bulgaria 1 0 0
Canada 70 8 3
China 0 0 1
Croatia 2 0 0
Czech Republic 0 2 0
Finland 1 0 0
France 1 0 1
Germany 20 2 0
Hong Kong 2 0 0
Hungary 1 0 0
Israel 1 0 1
Italy 1 0 0
Japan 4 2 1
Luxembourg 1 0 0
Malaysia 1 0 0
Mexico 5 0 0
Monaco 1 0 0
Netherlands 1 1 0
New Zealand 1 0 0
Norway 2 0 0
Portugal 4 0 1
Puerto Rico 1 0 0
Slovenia 0 1 0
Spain 5 0 2
Sweden 1 1 0
Switzerland 2 1 0
Taiwan 1 0 0
Thailand 3 0 1
UK 40 5 3
USA 1151 68 164
Totals 1338 96 181
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2021-02-28 01:55:392021-02-28 01:55:41Alcor Members and Patients: Where and How Many?
In order to advance the science and reputation of cryonics, Alcor plans to conduct ongoing research to develop novel and near-future products related to cryopreservation procedures and protocols. The RAPID team is developing relationships and contracts to procure recently deceased human cadavers, which are not Alcor members or patients, but are already earmarked for medical research. The idea is to procure one to two cadavers per month to conduct research. We would go a “light standby” to enable fast access to cadavers.
The RAPID initiative will support cryonics research in multiple ways. Most immediately, it will help advance research into liquid ventilation – using a patient’s lungs as a heat exchanger to induce very rapid hypothermia. Animal studies along cannot take LV development to the next level due to different chest anatomy. LV research will include cooling rate control; chest compression studies; and timing and sensor feedback.
RAPID will also enable research comparing chemical fixation to perfusion and will support rewarming studies. Another benefit will be a great improvement in cryonics-specific surgical training. That includes raising and cannulating the carotids; cephalic isolation; raising and cannulating the femoral arteries; field neuro procedure training; median sternotomy training; and alternate surgical approaches.
Alcor is requesting donations through gofundme. All donors will receive quarterly reports from Alcor regarding the progress with fundraising and milestone achievements rising from the RAPID program! Please donate today to support Alcor’s RAPID initiative. Alcor is a non-profit, federally tax-exempt, 501(c)(3) corporation and your donation may be tax deductible. Donate here. For more information, see the presentation here.
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2020-12-18 23:19:182020-12-18 23:22:03Support our new research initiative: RAPID! (Readiness And Procedure Innovation/Deployment)
A-2705 was a 67-year-old male with neuro cryopreservation arrangements who used the death with dignity laws in his state to legally terminate his life. His cause of death was kidney failure. He was pronounced legally deceased in August in the state of Washington at 17:17 hrs on T-0 days.
A field cryoprotection (FCP) was performed before the patient was transported to Alcor. Dry ice cooldown was initiated in the field at 23:49 hrs on T-0 days. Cryogenic cooldown was initiated at Alcor at 15.05 on T+1 days and terminated on T+5 at 18.33. The patient underwent a CT scan while remaining under liquid nitrogen. At the time of writing, A-2705 is still in a small dewar with the transfer to long-term storage yet to take place.
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2020-11-21 00:22:032020-11-21 00:22:06A-2705 became Alcor’s 181st patient in August 2020
It has been about five months since I last wrote an update on the COVID-19 situation in Arizona. For those living here or considering moving here to be closer to Alcor, it’s time for a current look at the situation.
Between my June 10 and June 16 posts, COVID cases in Arizona went up from 29,852 to 39,097 to a total of 40,924 – what seemed like a rapid pace. At that time, Arizona was one of the top 5 states for new cases and new deaths, and the peak was still several weeks away. The 7-day moving average (7-DMA) had run up from 339 on May 27 to 1,356 on June 17. Daily cases reached its peak (so far) on June 29 at 5450. At that time, Arizona ranked #20 in cases per capita and #23 in deaths per capita. Our worst day so far saw 103 deaths on July 17. How does that compare to today and to the rest of the country? (NOTE: By “cases” I mean reported positive diagnostic tests. That someone has tested positive does not mean they are sick or feel sick.)
Just one month ago, the situation looked relatively encouraging. In that month, the number of new cases has accelerated hard, as it has in many states, and the number of new deaths has also been moving up, although more slowly. Today, Arizona has 291,696 cases with today’s increase of 4,471 being the largest in months. The 7-DMA is 3166. We are now well into the red zone with 43.5 daily new cases per 100,000 (25 is considered critical). After doing badly, Arizona has been falling in the ranks of cases per capita and is currently at #25 and is closing in on the average (mean) for the USA as a whole.
The 7-DMA for new deaths has risen from 10 one month ago to 24.3 today.
The positivity rate on diagnostic tests has risen from 5.4% (or 7%, depending on the source) to 12% (or 10.5%). The infection rate has been rising since it reached a low in August.
In the last month, the number of people hospitalized has risen from 947 to 2266. ICU headroom use has risen from 19% to 46% and is close to reaching the “medium” level according to Covidactnow.
But is Arizona doing better or worse than other states? Is it a place to come to or to stay away from? The states with the most Alcor members are California, Texas, Florida, and Arizona. In recent months, Arizona has been doing better than Texas and Florida, although both of those states have been doing better than average. California, so far, despite having the second-largest number of identified cases has been suffering from lower population-adjusted cases and deaths. Like many other states, however, the curves are rising quickly. Among these states, currently none looks likely to be much better or worse than the others.
These four states all look relatively good if you compare them to the country as whole and many specific states. COVID-19 growth appears to not only be resurgent but disproportionately affecting more rural areas. Maine and Vermont, so far, have fared quite well, whereas states such as North and South Dakota, Iowa, Wyoming, Nebraska, Minnesota, Wisconsin, and Kansas are seeing high growth in daily cases and high infection rates.
How will COVID-19 play out in Arizona? I’m not going to guess. We have seen trends reverse themselves abruptly and dramatically. Cases in Arizona have been accelerating despite far more people wearing masks (compared to the spring and summer). The influx of “snowbirds” from states with much faster growth in cases could kick up our own numbers drastically. The coming vaccines – and better treatments than we had in the last peak – could hold down the growth in deaths.
At Alcor, we continue to take precautions. Some staff are working entirely from home; others in part. We are still not giving in-person tours, having replaced them with filmed “virtual tours”. Fortunately, we haven’t had a cryopreservation in months, so haven’t had to worry about airplane travel.
Stay safe. And contact Alcor’s Medical Response Director if you have any serious medical issue, COVID-related or otherwise.
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2020-11-21 00:20:502020-11-21 23:45:35November 20, 2020 update on COVID-19 in Arizona
Alcor will not be able to revive any patients for many decades to come. Although that time is a long way off, we should be thinking about it and planning for it now. For one thing, that’s part of Alcor’s mission: “Future restoration of good health and reintegration into society for all patients.”
Cryonics will be less scary to some if we have a clearer picture of the challenges revived patients will face and the ways we can prepare for them. The Reintegration Working Group (RWG) aims to develop ideas and plans relating to:
Asset trusts and future-income trusts
“Memory books” and ways to fill in any missing memories
Legal structures to allow patients to claim their identities and their status as persons
An organizational culture that fosters interest in and desire to help those who return from biostasis.
Supporting and protecting newly revived patients as they gradually reintegrate into the new world
Facilitating contact with other revived cryonauts, if this is desired.
Are you interested in this work? If so, what can you contribute? If you want to inquire about participating, email me.
–Max More
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2020-10-24 03:06:002020-10-24 03:06:02Introducing the Reintegration Working Group
During the coronavirus pandemic, Alcor has had to curtail in-person tours. We are currently arranging to offer virtual tours. When you book a tour, you will receive a link to view a video of a tour conducted by Dr. Max More, Alcor’s Ambassador & President Emeritus. During this video tour, many of your questions will be answered. However, you will have an opportunity to ask additional questions during or following the virtual tour.
We will likely revise the virtual tour, including creating a more technical version for those with more scientific and technically oriented questions. To help us provide you and other future virtual visitors with a maximally informative and useful tour, please send us your questions. Some of the questions that will be answered include:
Introduction:
What kind of organization is Alcor?
How long has it been in operation and what are the highlights of Alcor’s history?
How many members and patients does Alcor have?
Is cryonics unique or does it have anything in common with low-temperature surgery or freezing sperm or eggs?
When was the first person frozen?
Standby, Stabilization, and Transport section:
How does Alcor know when a member needs to be cryopreserved and how quickly can that happen?
What procedures do you use to keep human tissues viable until you can cryogenically preserve them? Is it anything like CPR? Or like transporting organs for transplant?
How soon must Alcor’s team get to the member after legal death? Is there a limit?
Can you start the procedure before legal death?
Operating Room/Perfusion section:
Doesn’t ice badly damage human cells? Or do you have a way of preventing that?
Why do you have a CT scanner in the operating room?
How does a brain-only or “neuro” case differ from a whole-body cryopreservation?
Why do many members choose the neuro option?
Patient Care section:
Are cryonics patients alive? Dead? Something else?
How long can patients stay cryopreserved?
Is it true that baseball great, Ted Williams, is one of your patients? Who else do you have who is famous? (Or why can’t you tell me?)
Would you revive anyone before a solution to the problem of aging has been found?
Post-tour section:
How much does all this cost, and can I pay for it with life insurance?
Who will take care of me if I am revived?
Will I have any money or be able to make an income? Is there any way to take my money with me and my loved ones?
Can I ask to be revived only if my spouse/siblings/offspring/parents can be revived?
What will the world be like if I am revived?
When do you think people will be revived? What technologies will make that possible?
Won’t there be too many people in the future already?
What if I want to do this but my spouse/family/friends are against it?
Why have so few people signed up to be cryopreserved?
Why would I want to be cryopreserved rather than eaten by worms and bacteria or incinerated in a large oven?
Is there any tension between cryonics and religions?
Technical questions, probably for a separate, optional section:
You say you don’t really, literally freeze people, but instead “vitrify” them. What does that mean?
Is it true that the brain dies after three minutes without oxygen?
Why is it that we can cryopreserve skin, corneas, eggs, sperm, and heart valves and rewarm and implant them but we cannot yet revive whole humans or human brains?
/wp-content/uploads/2019/08/logo.png00Max More/wp-content/uploads/2019/08/logo.pngMax More2020-10-23 20:50:462020-10-23 20:50:49What questions would you ask during a tour of Alcor?
